Sinovac Biotech singles out infectious illnesses such as hepatitis A and pandemic influenza for its vaccine development programs. The company has commercialized vaccines for ailments such as hepatitis A (under the Healive brand), seasonal influenza (Anflu), and pandemic influenza strains (Panflu) in select global markets (primarily China). Sinovac has other vaccines under development for disease targets including pneumonia and meningitis. Through its Tangshan Yian subsidiary, the company is also researching vaccines with applications in the animal health industry.